FluoGuide Past Earnings Performance
Past criteria checks 0/6
FluoGuide's earnings have been declining at an average annual rate of -27.7%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 46.7% per year.
Key information
-27.7%
Earnings growth rate
-18.1%
EPS growth rate
Biotechs Industry Growth | 0.7% |
Revenue growth rate | -46.7% |
Return on equity | -618.3% |
Net Margin | -9,494.3% |
Next Earnings Update | 29 Aug 2024 |
Recent past performance updates
Recent updates
Companies Like FluoGuide (STO:FLUO) Are In A Position To Invest In Growth
Jan 27FluoGuide (STO:FLUO) Is In A Good Position To Deliver On Growth Plans
Oct 07We're Hopeful That FluoGuide (STO:FLUO) Will Use Its Cash Wisely
May 21FluoGuide (STO:FLUO) Is In A Good Position To Deliver On Growth Plans
Jan 31Companies Like FluoGuide (STO:FLUO) Are In A Position To Invest In Growth
Feb 25Revenue & Expenses Breakdown
How FluoGuide makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 0 | -36 | 41 | 0 |
31 Dec 23 | 0 | -38 | 44 | 0 |
30 Sep 23 | 0 | -37 | 39 | 0 |
30 Jun 23 | 0 | -34 | 38 | 0 |
31 Mar 23 | 3 | -33 | 47 | 0 |
31 Dec 22 | 7 | -27 | 39 | 0 |
30 Sep 22 | 8 | -25 | 36 | 0 |
30 Jun 22 | 10 | -26 | 40 | 0 |
31 Mar 22 | 13 | -24 | 40 | 0 |
31 Dec 21 | 10 | -24 | 38 | 0 |
30 Sep 21 | 8 | -22 | 36 | 0 |
30 Jun 21 | 6 | -17 | 29 | 0 |
31 Mar 21 | 0 | -18 | 27 | 0 |
31 Dec 20 | 0 | -17 | 25 | 0 |
30 Sep 20 | 0 | -14 | 12 | 0 |
30 Jun 20 | 0 | -16 | 11 | 0 |
31 Mar 20 | 0 | -12 | 11 | 0 |
31 Dec 19 | 0 | -10 | 11 | 0 |
Quality Earnings: FLUO is currently unprofitable.
Growing Profit Margin: FLUO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: FLUO is unprofitable, and losses have increased over the past 5 years at a rate of 27.7% per year.
Accelerating Growth: Unable to compare FLUO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: FLUO is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (2.8%).
Return on Equity
High ROE: FLUO has a negative Return on Equity (-618.31%), as it is currently unprofitable.